Literature DB >> 29769406

Spindle Assembly Disruption and Cancer Cell Apoptosis with a CLTC-Binding Compound.

Michael J Bond1,2, Marina Bleiler1, Lauren E Harrison1, Eric W Scocchera3, Masako Nakanishi4, Narendran G-Dayanan3, Santosh Keshipeddy3, Daniel W Rosenberg4, Dennis L Wright3, Charles Giardina5.   

Abstract

AK3 compounds are mitotic arrest agents that induce high levels of γH2AX during mitosis and apoptosis following release from arrest. We synthesized a potent AK3 derivative, AK306, that induced arrest and apoptosis of the HCT116 colon cancer cell line with an EC50 of approximately 50 nmol/L. AK306 was active on a broad spectrum of cancer cell lines with total growth inhibition values ranging from approximately 25 nmol/L to 25 μmol/L. Using biotin and BODIPY-linked derivatives of AK306, binding to clathrin heavy chain (CLTC/CHC) was observed, a protein with roles in endocytosis and mitosis. AK306 inhibited mitosis and endocytosis, while disrupting CHC cellular localization. Cells arrested in mitosis by AK306 showed the formation of multiple microtubule-organizing centers consisting of pericentrin, γ-tubulin, and Aurora A foci, without apparent centrosome amplification. Cells released from AK306 arrest were unable to form bipolar spindles, unlike nocodazole-released cells that reformed spindles and completed division. Like AK306, CHC siRNA knockdown disrupted spindle formation and activated p53. A short-term (3-day) treatment of tumor-bearing APC-mutant mice with AK306 increased apoptosis in tumors, but not normal mucosa. These findings indicate that targeting the mitotic CHC complex can selectively induce apoptosis and may have therapeutic value.Implication: Disruption of clathrin with a small-molecule inhibitor, AK306, selectively induces apoptosis in cancer cells by disrupting bipolar spindle formation. Mol Cancer Res; 16(9); 1361-72. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29769406      PMCID: PMC6125173          DOI: 10.1158/1541-7786.MCR-18-0178

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  56 in total

Review 1.  Centrosomes and cancer: revisiting a long-standing relationship.

Authors:  Pierre Gönczy
Journal:  Nat Rev Cancer       Date:  2015-11       Impact factor: 60.716

Review 2.  Mitotic catastrophe: a mechanism for avoiding genomic instability.

Authors:  Ilio Vitale; Lorenzo Galluzzi; Maria Castedo; Guido Kroemer
Journal:  Nat Rev Mol Cell Biol       Date:  2011-04-29       Impact factor: 94.444

Review 3.  Genomic instability and cancer: networks involved in response to DNA damage.

Authors:  Jorunn Erla Eyfjord; Sigridur Klara Bodvarsdottir
Journal:  Mutat Res       Date:  2005-07-05       Impact factor: 2.433

4.  ATM is activated by mitotic stress and suppresses centrosome amplification in primary but not in tumor cells.

Authors:  Kate Shen; Yaolin Wang; S C Brooks; Avraham Raz; Y Alan Wang
Journal:  J Cell Biochem       Date:  2006-12-01       Impact factor: 4.429

5.  Mutation analysis of hBUB1, human mitotic checkpoint gene in multiple carcinomas.

Authors:  K Mimori; H Inoue; H Alder; H Ueo; Y Tanaka; M Mori
Journal:  Oncol Rep       Date:  2001 Jan-Feb       Impact factor: 3.906

Review 6.  Anti-mitotic agents: Are they emerging molecules for cancer treatment?

Authors:  Larissa Siqueira Penna; João Antonio Pêgas Henriques; Diego Bonatto
Journal:  Pharmacol Ther       Date:  2017-02-04       Impact factor: 12.310

Review 7.  p53 and ATM: cell cycle, cell death, and cancer.

Authors:  S E Morgan; M B Kastan
Journal:  Adv Cancer Res       Date:  1997       Impact factor: 6.242

Review 8.  The Mad1-Mad2 balancing act--a damaged spindle checkpoint in chromosome instability and cancer.

Authors:  Scott C Schuyler; Yueh-Fu Wu; Vivian Jen-Wei Kuan
Journal:  J Cell Sci       Date:  2012-10-23       Impact factor: 5.285

9.  Clathrin-mediated endocytic proteins are involved in regulating mitotic progression and completion.

Authors:  Charlotte M Smith; Megan Chircop
Journal:  Traffic       Date:  2012-09-07       Impact factor: 6.215

10.  Clathrin promotes centrosome integrity in early mitosis through stabilization of centrosomal ch-TOG.

Authors:  Amy B Foraker; Stéphane M Camus; Timothy M Evans; Sophia R Majeed; Chih-Ying Chen; Sabrina B Taner; Ivan R Corrêa; Stephen J Doxsey; Frances M Brodsky
Journal:  J Cell Biol       Date:  2012-08-13       Impact factor: 10.539

View more
  3 in total

1.  Predicting and affecting response to cancer therapy based on pathway-level biomarkers.

Authors:  Rotem Ben-Hamo; Adi Jacob Berger; Nancy Gavert; Mendy Miller; Guy Pines; Roni Oren; Eli Pikarsky; Cyril H Benes; Tzahi Neuman; Yaara Zwang; Sol Efroni; Gad Getz; Ravid Straussman
Journal:  Nat Commun       Date:  2020-07-03       Impact factor: 14.919

2.  A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.

Authors:  KunZhe Wu; ChunDong Zhang; Cheng Zhang; DongQiu Dai
Journal:  Biomed Res Int       Date:  2020-02-10       Impact factor: 3.411

3.  Deregulation of CLTC interacts with TFG, facilitating osteosarcoma via the TGF-beta and AKT/mTOR signaling pathways.

Authors:  Li Shijie; Pan Zhen; Qin Kang; Guo Hua; Yang Qingcheng; Cheng Dongdong
Journal:  Clin Transl Med       Date:  2021-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.